Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Understanding when and how to adjust a zero based budget helps you stay aligned with goals. Explore timing, methods, and best practices.
28,655 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
SPHD has sustained monthly distributions since its inception by tapping a mix of high-yield, low-volatility holdings....
A veteran economist warns that the long-standing cushion for markets is thinning. AI-driven gains mask growing vulner...
Bitcoin, Ethereum, and XRP have tumbled as political shifts sharpen policy debates on crypto. This report breaks down...
An obscure AI-focused ETF has outperformed the Nasdaq by concentrating on hard-to-access AI players in Korea and Taiw...
Late-career workers who enroll in Medicare while still employed and continue HSA deposits risk a 6% annual excise tax...
A 66-year-old with $1.1 million in an IRA discovers that most of her wealth is tied to future taxes and mandatory wit...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...
Netflix is set to release its Q2 earnings after the bell tonight, with investors watching ad revenue growth, content ...
November 2025 marks a new milestone as the Bitcoin Lightning Network surpasses $1B in monthly volume, signaling a shi...
The latest Freddie Mac survey shows the 30-year fixed rate dipping under 6% for the first time in years, signaling po...
As rates cool, Angel Oak’s Hutchens charts a growth path for non-QM lending with a sharper focus on product expansion...